Treatment for Foot Drop in Multiple Sclerosis
Links shared publicly online about this topic
Little pill means big news in the treatment of MS
eurekalert.org — “A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London. A major trial of the oral drug Cladribine -- results of which are published in the NEJM on Jan. 20, 2010 -- has shown that it significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.” View full resource at eurekalert.org
Most Recently Shared on January 21, 2010 at 10:33 am By:
Stephen Roberts, MD Physician and Doctor
Little pill big news 4 #MS - Cladribine 8x/yr => 55% drop relapse & 30% less progression #MultipleSclerosis http://bit.ly/7JwIMw
Study Suggests Functional Electrical Stimulation Device Improves Mobility in People with MS and Foot Drop : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on September 17, 2010 at 3:11 pm By:
News! Study Suggests Functional Electrical Stimulation Device Improves Mobility in People with MS and Foot Drop http://bit.ly/a1Y1o2
FDA approves drug for multiple sclerosis - CNN.com
cnn.com — “The second-to-last time EJ Levy was at Disney World, she used a scooter to navigate the enormous park. Her legs were weak and she suffered from foot drop caused by multiple sclerosis. That was 4" years ago. On her most recent trip, a few months ago, Levy walked the entire time, thanks in part to a drug approved by the FDA on Friday.” View full resource at cnn.com
Most Recently Shared on January 26, 2010 at 4:01 pm By:
KNB Communications Health Marketing
RT @Silverman_Josh: CNN - FDA approves drug from Acorda Therapeutics for multiple sclerosis - http://bit.ly/77DgsM #cnn
FDA approves drug for multiple sclerosis - CNN.com
rss.cnn.com — “The second-to-last time EJ Levy was at Disney World, she used a scooter to navigate the enormous park. Her legs were weak and she suffered from foot drop caused by multiple sclerosis. That was 4" years ago. On her most recent trip, a few months ago, Levy walked the entire time, thanks in part to a drug approved by the FDA on Friday.” View full resource at rss.cnn.com
Most Recently Shared on January 23, 2010 at 2:26 am By:
FDA OKs drug for multiple sclerosis http://bit.ly/4t2ktl
Analyst drops Teva Pharmaceutical to 'perform' - Yahoo! News
news.yahoo.com — “Read 'Analyst drops Teva Pharmaceutical to 'perform'' on Yahoo! News. Teva Pharmaceutical Industries Ltd. faces growing challenges and uncertainty surrounding its multiple sclerosis treatments, according to an Oppenheimer analyst.” View full resource at news.yahoo.com
Most Recently Shared on August 2, 2011 at 8:18 pm By:
Analyst drops Teva Pharmaceutical to 'perform': Teva Pharmaceutical Industries Ltd. faces growing challenges an... http://yhoo.it/oXqMGX
MS Society of Canada - News in Research
mssociety.ca — “MS Society of Canada - News in Research” View full resource at mssociety.ca
Most Recently Shared on July 26, 2010 at 10:54 pm By:
George Jelinek Doctor, Emergency Physician, and Physician
Electrical foot drop stimulator improves walking in secondary progressive MS and reduces falls http://bit.ly/cZBjJH
Teva Posting Biggest Healthcare Drop in U.S.: Israel Overnight - Bloomberg
bloomberg.com — “Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is posting the biggest decline among U.S.-traded healthcare companies on concern its multiple sclerosis treatment won’t receive approval from American regulators.” View full resource at bloomberg.com
Most Recently Shared on August 2, 2011 at 10:37 pm By:
Teva Posting Biggest Healthcare Drop in U.S.: Israel Overnight: By Tal Barak Harif and Naomi Kresge - Tue Aug 02... http://bit.ly/pJve40
Copaxone Market Share Drops in November - Drugs.com MedNews
drugs.com — “Copaxone market share drops in November Globes, Tel Aviv, Israel From Globes (Tel Aviv) (December 19, 2010) Barclays Capital analysts Richard Silver and Ann Tri” View full resource at drugs.com
Most Recently Shared on December 20, 2010 at 3:02 pm By:
Drugs and Devices OW OW Health
Copaxone Market Share Drops in November: Copaxone market share drops in November [Globes, Tel Aviv, Israel... http://bit.ly/h2ua82 #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Stephen Roberts, MD
-
National MS Society
Multiple sclerosis stops people from moving. We exist to make sure it doesn't.
-
KNB Communications
PR for Healthcare Technology
Advertisement
